EUS-guided fiducial placement in pancreatic tumors is a technically successfull and safe procedure. After placement fiducials can be successfully used for highly-accurate delivery of image-guided radiotherapy.
ID
Bron
Aandoening
Patients with (borderline) resectable or locally advanced pancreatic cancer with an indication for radiochemotherapy
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Clinical success: defined as the ability to use the fiducials in applying image-guided radiotherapy
Doel van het onderzoek
EUS-guided fiducial placement in pancreatic tumors is a technically successfull and safe procedure. After placement fiducials can be successfully used for highly-accurate delivery of image-guided radiotherapy.
Onderzoeksopzet
Follow-up call/visit for complications: 48-72 hours, 7 days and 30 days post-procedure
Onderzoeksproduct en/of interventie
EUS-guided placement of fiducials in a pancreatic tumor
Publiek
Academic Medical Center
Meibergdreef 9, C2-310
S. Lekkerkerker
Amsterdam 1105 AZ
The Netherlands
+31-205662061
s.j.lekkerkerker@amc.nl
Wetenschappelijk
Academic Medical Center
Meibergdreef 9, C2-310
S. Lekkerkerker
Amsterdam 1105 AZ
The Netherlands
+31-205662061
s.j.lekkerkerker@amc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
• Patient over 17 years old;
• Indication for radio(chemo)therapy for pancreatic carcinoma;
• WHO performance status of 0-2;
• Verbal informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
• Altered anatomy of the pancreatic region;
• Any contraindication for EUS-guided fiducial placement.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4252 |
| NTR-old | NTR4490 |
| Ander register | METC AMC : W14_021 |